124 related articles for article (PubMed ID: 34019044)
21. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
22. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
[TBL] [Abstract][Full Text] [Related]
23. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
24. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
25. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
26. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
27. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
28. Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy.
Hu H; Yang W; Liang Z; Zhou Z; Song Q; Liu W; Deng X; Zhu J; Xing X; Zhong B; Wang B; Wang S; Shao Z; Zhang Y
J Nanobiotechnology; 2021 Jul; 19(1):221. PubMed ID: 34315494
[TBL] [Abstract][Full Text] [Related]
29. Mannosylated poly(acrylic acid)-coated mesoporous silica nanoparticles for anticancer therapy.
Lee H; Choi M; Kim HE; Jin M; Jeon WJ; Jung M; Yoo H; Won JH; Na YG; Lee JY; Seong H; Lee HK; Cho CW
J Control Release; 2022 Sep; 349():241-253. PubMed ID: 35798094
[TBL] [Abstract][Full Text] [Related]
30. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
[TBL] [Abstract][Full Text] [Related]
31. Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells.
Liu T; Zeng L; Jiang W; Fu Y; Zheng W; Chen T
Nanomedicine; 2015 May; 11(4):947-58. PubMed ID: 25680543
[TBL] [Abstract][Full Text] [Related]
32. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
33. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors.
Choi JY; Gupta B; Ramasamy T; Jeong JH; Jin SG; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 May; 165():56-66. PubMed ID: 29453086
[TBL] [Abstract][Full Text] [Related]
34. Se@SiO
Wang Y; Liu X; Deng G; Sun J; Yuan H; Li Q; Wang Q; Lu J
Nanoscale; 2018 Feb; 10(6):2866-2875. PubMed ID: 29367975
[TBL] [Abstract][Full Text] [Related]
35. Designing Core-Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy.
Chang Y; He L; Li Z; Zeng L; Song Z; Li P; Chan L; You Y; Yu XF; Chu PK; Chen T
ACS Nano; 2017 May; 11(5):4848-4858. PubMed ID: 28460158
[TBL] [Abstract][Full Text] [Related]
36. Targeted antimicrobial peptide delivery in vivo to tumor with near infrared photoactivated mesoporous silica nanoparticles.
Dong W; Wen J; Li Y; Wang C; Sun S; Shang D
Int J Pharm; 2020 Oct; 588():119767. PubMed ID: 32800935
[TBL] [Abstract][Full Text] [Related]
37. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
38. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy.
N VR; Han HS; Lee H; Nguyen VQ; Jeon S; Jung DW; Lee J; Yi GR; Park JH
Nanoscale; 2018 May; 10(20):9616-9627. PubMed ID: 29756137
[TBL] [Abstract][Full Text] [Related]
39. Construction of selenium-embedded mesoporous silica with improved antibacterial activity.
Chen J; Wei Y; Yang X; Ni S; Hong F; Ni S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110910. PubMed ID: 32126358
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]